HIVMicrobiome
Meeting category
Date(s)
17 Nov 2016 - 18 Nov 2016
Location
Bethesda, United States
Organizer
Platinum Level Support
Sponsor logos
ViiW

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Related Enduring Materials

Enduring Materials

Day 1 - Thursday, 17 November 2016

Welcome -
Key note: Systems Biology, Modeling, and Cross-Meta-Omic Analysis of the Human Microbiome
Elhanan Borenstein
Elhanan Borenstein, PhD
University of Washington
Session 1: Pathogenesis -
Chairs
Alan Landay, PhD
Rush University Medical Center, United States
Functional Role of Gut Microbiota in Chronic Liver Disease
Gary Wu
Gary Wu, MD
University of Pennsylvania
Lung Microbiome & HIV
Ron Collman
Ron Collman, MD
University of Pennsylvania
Differences in gut microbiota related metabolic pathways between Elite Controllers and HIV-progressors
J. Vesterbacka
#1
Human gut microbial gene richness correlates with HIV infection
Y. Guillén
#2
Session 2: Transmission and Prevention (Microbicides) -
Chairs
Satya Dandekar, PhD
University of California, Davis, United States
Mother to Infant Transmission
Grace Aldrovandi, MD, CM
University of California, Los Angeles, United States
Live Biotherapeutics: How the Vaginal Microbiome Can be Modified to Prevent HIV Infection
Laurel Lagenaur, PhD
NIH, Osel, United States
Cervicovaginal bacteria impact HIV acquisition in young South-African women
C. Gosmann
#3
Session 3: Round table discussion: Steps forward -
The NIH’s human microbiome project
Lita Proctor
Lita Proctor, PhD
National Institute of Health

DAY 2 - Friday, 18 November 2016

Session 4: Comorbidities -
Chairs
Ronald Collman
Ronald Collman, MD
NIH, United States
Role of the Microbiota in the Control of Tissue Immunity
Yasmine Belkaid
Yasmine Belkaid, PhD
National Institute of Health / Division of Intramural Research
The Human Microbiome and Cancer: New Opportunities For Population Studies
Emily Vogtmann
Emily Vogtmann, PhD, MPH
National Institute of Health / National Cancer Institute
Oral microbiota in relation to HIV infection and oral infection in perinatally HIV-infected adolescents
Bruce Paster
Bruce Paster, PhD
The Forsyth Institute
Case Control study of the oral microbiome in HIV uninfected individuals compared to HIV positive individuals before and after HAART
D. Malamud
#4
Session 5: Microbiome & Vaccines -
Chairs
Stacy Carrington-Lawrence, PhD
Stacy Carrington-Lawrence, PhD
NIH, USA
Angela Malaspina
Angela Malaspina, PhD
NIAID/NIH, USA
The “Window of Opportunity”: Harnessing the Pediatric Immune Landscape for Life-Long Vaccine- Elicited Protection
Sallie Permar
Sallie Permar, MD, PhD
Duke University School of Medicine
Influence of the Microbiota on Immune Responses to RhCMV/SIV Vaccines
Dennis Hartigan
Dennis Hartigan-O’Connor, MD, PhD
University of California
The Impact of Age and Diet on the Non-Human Primate Microbiota
Ivona Pandrea
Ivona Pandrea, MD, PhD
University of Pittsburgh
Session 6: Virome and Mycobiome -
Chairs
Stacy Carrington-Lawrence, PhD
Stacy Carrington-Lawrence, PhD
NIH, USA
The Impact of Age and Diet on the Non-Human Primate Microbiota
Ivona Pandrea
Ivona Pandrea MD, PhD
University of Pittsburgh
The Mycobiome and How it Influences Disease
Mahmoud Ghannoum
Mahmoud Ghannoum, PhD, MBA
Case Western University
Enteric virome analysis of non-invasive samples from gorillas by next-generation sequencing and association with SIV infection
M. D’arc
#5
Alterations in the Enteric Microbiome and Virome and Immune Activation among HIV-infected Individuals in Sub-Saharan Africa and the United States
D. Gootenberg
#6
Overview
Welcome

The very successful 2nd edition of the International Workshop on Microbiome in HIV took place on 17 and 18 November 2016 in NIH Campus in Bethesda, MD, USA.

The Organizing Committee would like to thank all invited speakers and participants for their contribution to this workshop!

We would like to thank our supporters ViiV Healthcare, Siemens Healthnieers, affymetrix, NIH and NIAID for making this event possible.

Chair

General Information 

Unique Features
The meeting features for the workshop are to its multidisciplinary nature and significance in enabling to learn how the host microbiome can influence responses to our current HIV therapies, and to further our ability to develop novel prevention and therapeutic strategies for HIV that will lead to the reduction of new HIV infections and the burden of non-communicable diseases in HIV infected subjects.
Meeting Objectives
This meeting aims to:

- To gather cross-disciplinary professionals in the field of microbiome research to provide a better understanding of the impact of microbiome changes on HIV outcomes

- To develop a better understanding of how the microbiome effects the pathogenesis of HIV across mucosal sites

- To enhance our knowledge of how the microbiome can impact vaccine responses

- To better understand how the microbiome can contribute to the development of non-communicable diseases

- To use our knowledge of the microbiome field in developing novel strategies for developing microbicides for HIV prevention

- To bring together scientists from across the globe to enhance our understanding of how we can use approaches to modulate the microbiome to reduce levels of inflammation

- To bring together bioinformatics experts in enhancing our ability to analyze complex data generated by sequencing the host microbiome





Learning Objectives
After participating in this activity, participants will be able to:

- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium

- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium

- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium

Practical Information 

Language
The official language of the workshop was English.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Support
Platinum Level
Bronze Level
Co-Organized by:
Endorsers